The agrochemicals industry reached USD 1,342 million in 2023. It’s expected to keep rising at around 7.6% CAGR every year until 2029. Mahamaya Lifesciences Limited, a company working in this sector, is gearing up for the IPO.
The IPO is managed by Oneview Corporate Advisors. Moreover, KFin Technologies is registering the issue. Check the Mahamaya Lifesciences IPO allotment status now.
To know more about the IPO, check out the Mahamaya Lifesciences IPO DRHP and RHP.
Note: 50% shares will be unlocked 30 days after allotment, while the rest will be free from lock-in restrictions after 90 days.
Here's everything about the Mahamaya Lifesciences Limited IPO.
Let's see the risks and strengths you should know about Mahamaya Lifesciences:
Trusted by Big Clients: The company has built lasting relationships with major customers who trust its products and services.
Knows the Market Well: With years of experience, the company understands what customers want and how the market works.
Growing Presence in India and Abroad: Even though it started locally, the company now supplies to international markets too.
Quality-Driven Production: The company’s manufacturing setup is quick to adjust to new demands while maintaining high quality.
Risks
Relying on a Few Big Clients: Most of the company’s sales come from just a handful of major customers. If even one of them stops or reduces orders, it could affect its business and growth.
No Long-Term Deals: The company doesn’t have fixed contracts with customers or suppliers. So, if demand drops or there’s a supply issue, it might impact production and profits.
Product Approval Delays: The company needs to get its products approved both in India and abroad. Any delay in these approvals could slow down exports.
Minor Payment Delays: While the company files everything on time, there have been a few small delays in payments.
As of November 4, 2025, the Mahamaya Lifesciences IPO GMP hasn’t been updated yet. You can see the IPO's live GMP and the subscription status. Also, check the Mahamaya Lifesciences RHP before you click on the Apply Now button.
1. How is the Mahamaya Lifesciences IPO review?
Mahamaya Lifesciences Limited is a cutting tools company. However, you can check the IPO date, size, and financials in its final prospectus. For the latest details, you can also look for the GMP updates.
2. What is the Mahamaya Lifesciences Ltd IPO date?
The IPO open date is November 11, 2025, and the close date is November 13, 2025. Live subscription details can be monitored through FinnPick.
3. What is the Mahamaya Lifesciences share price?
The Mahamaya Lifesciences share price target is ₹108 - ₹114 as of November 4, 2025. Also, don't forget to check the Mahamaya Lifesciences IPO news.
4. Should I use a demat account to bid for the Mahamaya Lifesciences Limited IPO?
Yes, a demat account is required to bid for the Mahamaya Lifesciences Limited IPO. Click here to get the ultimate list of the top demat account providers.
